How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,068 results for

Deep Vein Thrombosis of the Upper Extremity

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Rivaroxaban withdrawal and rebound hypercoagulability leading to upper extremity deep vein thrombosis: a case report. (Full text)

Rivaroxaban withdrawal and rebound hypercoagulability leading to upper extremity deep vein thrombosis: a case report. As the newer oral anticoagulants (NOACs) are increasingly used in older patients, clinical scenarios when they may need to be discontinued temporarily or indefinitely, may be encountered. Similarly with increasing use of permanent pacemakers and other intra-cardiac devices, there is an increased risk of upper limb venous thrombosis even few years after their insertion. We report (...) a case of a patient with a permanent pacemaker, on rivaroxaban (NOAC) for atrial fibrillation, who developed an upper extremity deep vein thrombosis after its temporary withdrawal following a traumatic acute subdural haematoma. Physicians should be aware of the possibility of rebound hypercoagulability and venous thrombosis soon after the withdrawal of NOACs.© The Author 2017. Published by Oxford University Press on behalf of the British Geriatrics Society.All rights reserved. For permissions, please

2017 Age and ageing PubMed abstract

22. Deep Vein Thrombosis of the Upper Extremity

Deep Vein Thrombosis of the Upper Extremity Deep Vein Thrombosis of the Upper Extremity Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration (...) 4 Deep Vein Thrombosis of the Upper Extremity Deep Vein Thrombosis of the Upper Extremity Aka: Deep Vein Thrombosis of the Upper Extremity , Upper Extremity DVT , PICC Line Thrombosis From Related Chapters II. Causes Central Venous Catheter (common) PICC Line Thrombosis (complicates 3-5% of s) External Vein Compression (Effort Thrombosis) Athletes with muscle hypertrophy Idiopathic (rare) Evaluate for occult cancer Consider evaluation for state III. Symptoms or of the hand or arm IV. Signs Arm

2018 FP Notebook

23. Diagnosis of deep vein thrombosis of the upper extremity: a systematic review of test accuracy

Diagnosis of deep vein thrombosis of the upper extremity: a systematic review of test accuracy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

24. Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism

with apixaban compared with rivaroxaban. Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (TA341) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 12 of 40However, the ERG was satisfied that the company's analyses provided in response to clarification resulted in less extreme estimates of the underlying treatment effect (that is, they were less likely to over (...) Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism Apixaban for the treatment and Apixaban for the treatment and secondary pre secondary prev vention of deep v ention of deep vein ein thrombosis and/or pulmonary embolism thrombosis and/or pulmonary embolism T echnology appraisal guidance Published: 4 June 2015 nice.org.uk/guidance/ta341 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions

2015 National Institute for Health and Clinical Excellence - Technology Appraisals

25. Primary Upper Limb Deep Vein Thrombosis. Is First Rib Resection Necessary?

information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Additional relevant MeSH terms: Layout table for MeSH terms Thrombosis Venous Thrombosis Upper Extremity Deep Vein Thrombosis Embolism and Thrombosis Vascular Diseases Cardiovascular Diseases (...) Primary Upper Limb Deep Vein Thrombosis. Is First Rib Resection Necessary? Primary Upper Limb Deep Vein Thrombosis. Is First Rib Resection Necessary? - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Primary

2018 Clinical Trials

26. Quality Improvement Guidelines for the Treatment of Lower-Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal

Quality Improvement Guidelines for the Treatment of Lower-Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal STANDARDS OF PRACTICE Quality Improvement Guidelines for the Treatment of Lower-Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal Suresh Vedantham, MD, Akhilesh K. Sista, MD, Seth J. Klein, MD, Lina Nayak, MD, Mahmood K. Razavi, MD, Sanjeeva P. Kalva, MD, Wael E. Saad, MD, Sean R. Dariushnia, MD, Drew M. Caplin, MD, Christine P. Chao, MD (...) by telephone conference calling or face- to-face meeting. The ?nalized draft from the Committee is sent to the SIR membership for further input/criticism during a 30-day comment period. These comments are discussed by the Standards of Practice Committee, and appropriate revisions are made to create the ?nished standards document. Before its publication, the document is endorsed by the SIR Executive Council. INTRODUCTION Lower-extremity deep vein thrombosis (DVT) is a serious medical condition that can

2014 Society of Interventional Radiology

27. Deep Vein Thrombosis: Diagnosis

to compare CUS results with those from prior examinations. Recurrent DVT can only be definitively diagnosed with evidence of new thrombosis, including non-compressibility in previously normal venous segments or increases of at least 4 mm in compression diameter from prior studies. Consultation with an expert in the field may be helpful when these occur or when no prior CUS is available for comparison. Upper extremity DVT (UEDVT): [See also Central Venous Catheter-Related Deep Vein Thrombosis guide] UEDVT (...) -test probability. The accuracy of this type of intuitive approach, however, is dependent on physician experience. Use of a structured score is encouraged. TABLE 1: TWO-LEVEL WELLS SCORE FOR DVT DIAGNOSIS CLINICAL FINDINGS POINTS Paralysis, paresis or recent orthopedic casting of lower extremity 1 Bedridden >3 days recently or major surgery within past 12 weeks 1 Localized tenderness of the deep veins 1 © 2016 Thrombosis Canada Page 2 of 6 Swelling of entire leg 1 Calf swelling 3 cm greater than

2016 Thrombosis Interest Group of Canada

28. Central Venous Catheter-Related Deep Vein Thrombosis

collateral veins on the chest, or symptoms of superior vena cava obstruction. Pulmonary embolism (PE) can occur in about 16% of all patients with catheter-associated DVT. The best initial test for diagnosing thrombosis is duplex ultrasonography, noting that it is less reliable for upper extremity than for lower extremity DVT due to the position of the clavicle. However, the sensitivity and specificity of this test are shown to be above 94%. In difficult cases, magnetic resonance imaging (MRI (...) ) and computed tomography (CT) can also be used. Venography is the gold standard but it is © 2013 Thrombosis Canada. Page 2 of 3 an invasive procedure and is often difficult to interpret. Lineograms, a radiographic study where contrast is injected into the catheter, are not recommended for excluding a diagnosis of catheter- related DVT. Post-thrombotic syndrome can occur in the upper extremity, and may manifest as chronic pain, swelling, edema, varicose veins and disability of the affected arm. TREATMENT

2015 Thrombosis Interest Group of Canada

29. Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines

Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines Canadian Agency for Drugs and Technologies in Health Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA (...) . No evaluation of the quality of this assessment has been made for the HTA database. Citation Canadian Agency for Drugs and Technologies in Health. Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2011 Authors' conclusions There is a lack of evidence on the maintenance of peripherally inserted central catheters after the development of upper extremity deep vein thrombosis

2011 Health Technology Assessment (HTA) Database.

30. The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients: A prospective study. (Full text)

The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients: A prospective study. Peripherally inserted central venous catheter (PICC) is the main venous access for cancer patients when they receive chemotherapy and nutritional support, but PICC-related venous thrombosis has become one of the most common and serious complications. It is very important to further explore the relationship among these features, so that prevent (...) and treat the PICC-related thrombosis.To investigate the clinical features and the related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients, and to provide theoretical basis for the prevention of venous thrombosis.A total of 127 tumor patients with PICC catheterization were selected. Thrombus was detected by color Doppler ultrasound at different times: before catheterization and 24 hours after catheterization, and every week. The study was terminated at the time

2020 Medicine PubMed abstract

31. Catheter-directed thrombolysis prevents post-thrombotic syndrome in patients with acute deep vein thrombosis in the upper half of the thigh

Catheter-directed thrombolysis prevents post-thrombotic syndrome in patients with acute deep vein thrombosis in the upper half of the thigh Catheter-directed thrombolysis prevents post-thrombotic syndrome in patients with acute deep vein thrombosis in the upper half of the thigh | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use (...) in the upper half of the thigh Article Text Therapeutics Catheter-directed thrombolysis prevents post-thrombotic syndrome in patients with acute deep vein thrombosis in the upper half of the thigh Anthony J Comerota Statistics from Altmetric.com Commentary on: Enden T , Haig Y , Kløw NE , et al . Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Context Post-thrombotic

2012 Evidence-Based Medicine

32. Deep Vein Thrombosis in Upper Limb in a Weightlifter (Full text)

Deep Vein Thrombosis in Upper Limb in a Weightlifter We report an unusual case of a male weightlifter with upper extremity venous thrombosis.Thrombosis affecting subclavian-axillo-humeral venous trunk produced by the compression of these veins by the trained muscles of the shoulder girdle (Paget-Schroetter syndrome) has been reported. During the study, a renal carcinoma was detected. Renal carcinoma has rarely been associated with thrombosis in the upper extremities.This case shows

2017 Open access Macedonian journal of medical sciences PubMed abstract

33. Post-thrombotic syndrome and recurrence rate in patients with primary upper extremity deep vein thrombosis: a systematic review and meta-analysis of proportions

Post-thrombotic syndrome and recurrence rate in patients with primary upper extremity deep vein thrombosis: a systematic review and meta-analysis of proportions Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2017 PROSPERO

34. Central Venous Catheters and Upper Extremity Deep Vein Thrombosis in Medical Inpatients: the Medical Inpatients and Thrombosis (MITH) study. (Full text)

Central Venous Catheters and Upper Extremity Deep Vein Thrombosis in Medical Inpatients: the Medical Inpatients and Thrombosis (MITH) study. Upper extremity deep vein thrombosis (UEDVT) is an increasingly recognized complication in medical inpatients, with few data available regarding the incidence, risk factors and association with central venous catheter (CVC) use.Between 2002 and 2009 all cases of hospital-acquired venous thromboembolism (VTE) at a university hospital were frequency matched (...) 1 : 2 to non-cases without VTE by admission year and medical service. Records were abstracted to identify, characterize and assess risk factors for UEDVT. Weighted logistic regression was used to calculate odds ratios (ORs) for UEDVT associated with use of a CVC, adjusting for known VTE risk factors.Two hundred and ninety-nine cases of VTE complicated 64 034 admissions to medical services (4.6 per 1000 admissions). UEDVT constituted 51% (91/180) of all deep vein thrombosis (DVT

2015 Journal of Thrombosis and Haemostasis PubMed abstract

35. Improving the diagnostic management of upper extremity deep vein thrombosis. (Full text)

Improving the diagnostic management of upper extremity deep vein thrombosis. Essentials The Constans score and D-dimer can rule out upper extremity deep vein thrombosis without imaging. We evaluated the performance of an extended Constans score and an age-adjusted D-dimer threshold. The extended Constans score did not increase the efficiency compared to the original score. Age-adjusted D-dimer testing safely increased the efficiency by 4%, but this needs validation.Background Among patients (...) with clinically suspected upper extremity deep vein thrombosis (UEDVT), a clinical decision rule based on the Constans score combined with D-dimer testing can safely rule out the diagnosis without imaging in approximately one-fifth of patients. Objectives To evaluate the performance of the original Constans score, an extended Constans score and an age-adjusted D-dimer positivity threshold. Methods Data of 406 patients with suspected UEDVT previously enrolled in a multinational diagnostic management study were

2016 Journal of Thrombosis and Haemostasis PubMed abstract

36. Paget-Schroetter syndrome: diagnostic limitations of imaging upper extremity deep vein thrombosis. (Abstract)

Paget-Schroetter syndrome: diagnostic limitations of imaging upper extremity deep vein thrombosis. Paget-Schroetter syndrome is a rare but potentially debilitating condition affecting young, otherwise healthy individuals. This condition, also known as effort thrombosis, is an upper extremity deep vein thrombosis classically caused by anatomical abnormalities compressing the neurovascular structures of the thoracic outlet. The diagnosis is important to emergency medicine providers due to its (...) upper extremity deep vein thromboses. The initial selected imaging study, Doppler ultrasound, was negative in our case and was followed by a nondiagnostic computed tomographic venogram. Although ultrasound is the preferred diagnostic imaging modality, it is limited when thrombosis is present in the noncompressible region of the clavicle. Magnetic resonance venogram or computed tomographic venogram is recommended if index of suspicion is high and the ultrasound shows normal results, but these studies

2016 American Journal of Emergency Medicine

37. Postoperative upper extremity deep vein thrombosis in a gynecologic oncology patient: A case report (Full text)

Postoperative upper extremity deep vein thrombosis in a gynecologic oncology patient: A case report Upper extremity deep vein thrombosis (UEDVT) represents approximately 10% of all thromboembolic events. It is a rare condition after a gynecologic surgery and highly related with pulmonary embolism.Herein, we present a very rare case of a unilateral left upper extremity deep vein thrombosis in a morbidly obese patient with synchronous primary cancers of endometrium and ovary.Our aim (...) was to underline the relationship between the presence of gynecologic malignancy, oncologic surgery and UEDVT.Upper extremity deep vein thrombosis should be kept in mind in the presence of any symptom on upper extremity during postoperative period even in patients without central venous catheter.Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

2016 International journal of surgery case reports PubMed abstract

38. Upper extremity deep vein thrombosis in a triathlete: Again intense endurance exercise as a thrombogenic risk. (Full text)

Upper extremity deep vein thrombosis in a triathlete: Again intense endurance exercise as a thrombogenic risk. Triathlon followers increase each year and long-distance events have seen major growth worldwide. In the cycling phase, athletes must maintain an aerodynamic posture on the bike for long periods of time. We report a case of a 38-year-old triathlete with symptoms of an axillary vein thrombosis 48h after a long triathlon competition. After 3days of hospitalization with a treatment (...) consisted on enoxaparin anticoagulant and acenocumarol, the patient was discharged with instructions to continue treatment under home hospitalization with acetaminophen. Four weeks after the process, the patient was asymptomatic and the diameter of his arm was near normality. Due to the growing popularity of events based on endurance exercise, it is necessary more research to determine the etiopathogeny of deep venous thrombosis in athletes.Copyright © 2016 Elsevier Inc. All rights reserved.

2016 American Journal of Emergency Medicine PubMed abstract

39. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review

Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

40. Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review. (Abstract)

Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review. The incidence of upper extremity deep vein thrombosis (UEDVT) is increasing. Information on the clinical course of UEDVT is scarce, especially in cancer patients.To summarize the clinical evidence regarding long-term clinical outcomes of UEDVT, in terms of recurrent venous thromboembolism (VTE), mortality, and anticoagulant-related bleeding, in patients with or without concomitant

2016 Thrombosis research

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>